Back to Market Feed

PRADAXA 150 MG CAPSULE

dabigatran etexilate mesylate
$3.1628per EA

Strength

150 mg/1

NDC

00597036082

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022512

On Market Since

7/28/2017

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.2%

3Y

-59.8%

5Y

-58.5%

All

-50.6%

Generic Alternatives

1 alternative • Same active ingredient

PRADAXA 150 MG CAPSULE
Brand
00597036055•Boehringer Ingelheim Pharmaceuticals Inc.
$3.1628

Related Drugs

Same classification

No related drugs found.